Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_assertion type Assertion NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_head.
- NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_provenance.
- NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_assertion evidence source_evidence_literature NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_provenance.
- NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_assertion SIO_000772 23633485 NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_provenance.
- NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_assertion wasDerivedFrom befree-20140225 NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_provenance.
- NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_assertion wasGeneratedBy ECO_0000203 NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_provenance.